Stay updated on Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial
Sign up to get notified when there's something new on the Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial page.

Latest updates to the Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial page
- Check5 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check12 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check19 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check26 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe webpage has been updated to include details about a new clinical study on Acute Decompensated Heart Failure, specifically focusing on the use of empagliflozin (Jardiance®) as a treatment. Key information about the study's design, medications, and collaborators has been added, while extensive background information on heart failure has been removed.SummaryDifference43%
Stay in the know with updates to Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Diuresis in Acute Decompensated HF Clinical Trial page.